New Non-Invasive Biosensor Aids Early Kidney Disease Detection
A novel biosensor detects SDMA in urine, providing a more accurate, non-invasive method for early kidney disease diagnosis and monitoring.
A novel biosensor detects SDMA in urine, providing a more accurate, non-invasive method for early kidney disease diagnosis and monitoring.
Promis Diagnostics recently presented data for CystoChek, a proprietary urine-based DNA methylation test of PENK for bladder cancer detection in hematuria.